Researchers are excited about the medication , a innovative dual compound showing significant outcomes in clinical trials for body loss . It acts by modulating two systems: GLP-1 and GIP, that , when https://esmeeyiot361448.blogs100.com/41170761/a-new-prospect-for-size-reduction